Shortage reports
Actual shortage:
257 (7%)
Anticipated shortage:
3 (0%)
Avoided shortage:
11 (0%)
Resolved:
3300 (92%)
3571
Discontinuation Reports
To be discontinued:
24 (7%)
Discontinued:
342 (93%)
Reversed:
0 (0%)
366
143 (4%)
32 (11%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-LANSOPRAZOLE | 15MG | CAPSULE (DELAYED RELEASE) | Resolved | 2022-12-16 | 2023-01-26 | 178754 |
| APO-LANSOPRAZOLE | 30MG | CAPSULE (DELAYED RELEASE) | Resolved | 2020-10-28 | 2020-11-09 | 127350 |
| APO-LANSOPRAZOLE | 15MG | CAPSULE (DELAYED RELEASE) | Resolved | 2020-10-14 | 2020-11-09 | 126286 |
| APO-LANSOPRAZOLE | 15MG | CAPSULE (DELAYED RELEASE) | Resolved | 2025-07-25 | 2025-08-01 | 263565 |
| APO-LANSOPRAZOLE | 30MG | CAPSULE (DELAYED RELEASE) | Resolved | 2024-06-20 | 2024-06-28 | 231024 |
| APO-LANSOPRAZOLE | 30MG | CAPSULE (DELAYED RELEASE) | Actual shortage | 2026-01-23 | 2026-01-23 | 276565 |
| APO-LANSOPRAZOLE | 30MG | CAPSULE (DELAYED RELEASE) | Resolved | 2025-03-27 | 2025-04-25 | 253493 |
| APO-LANSOPRAZOLE | 30MG | CAPSULE (DELAYED RELEASE) | Resolved | 2019-03-27 | 2019-04-26 | 79583 |
| APO-LATANOPROST | 50MCG | SOLUTION | Resolved | 2024-12-12 | 2025-06-27 | 245508 |
| APO-LATANOPROST | 50MCG | SOLUTION | Resolved | 2022-04-01 | 2022-09-23 | 157695 |
| APO-LATANOPROST | 50MCG | SOLUTION | Resolved | 2017-03-10 | 2020-02-13 | 363 |
| APO-LATANOPROST | 50MCG | SOLUTION | Resolved | 2024-06-20 | 2024-09-20 | 231039 |
| APO-LATANOPROST-TIMOP | 5MG 50MCG | SOLUTION | Resolved | 2017-03-13 | 2018-09-11 | 739 |
| APO-LEFLUNOMIDE | 20MG | TABLET | Resolved | 2024-04-26 | 2024-05-31 | 226315 |
| APO-LEFLUNOMIDE | 10MG | TABLET | Resolved | 2017-03-11 | 2017-05-23 | 667 |
| APO-LEFLUNOMIDE | 10MG | TABLET | Resolved | 2023-09-22 | 2023-11-10 | 205009 |
| APO-LEFLUNOMIDE | 20MG | TABLET | Resolved | 2019-11-27 | 2020-03-13 | 99789 |
| APO-LEFLUNOMIDE | 20MG | TABLET | Resolved | 2023-05-12 | 2023-06-02 | 192367 |
| APO-LEFLUNOMIDE | 10MG | TABLET | Resolved | 2022-11-11 | 2023-01-20 | 174338 |
| APO-LEFLUNOMIDE | 10MG | TABLET | Resolved | 2024-01-19 | 2024-02-09 | 216659 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-FENTANYL MATRIX | Discontinued | 2018-09-07 | 2018-09-15 | 60494 | ||
| APO-FENTANYL MATRIX | 75MCG | PATCH | Discontinued | 2018-09-07 | 2018-09-15 | 60497 |
| APO-FENTANYL MATRIX | 100MCG | PATCH | Discontinued | 2018-02-23 | 2018-12-28 | 40741 |
| APO-FENTANYL MATRIX | 25MCG | PATCH | Discontinued | 2018-09-07 | 2018-09-15 | 60489 |
| APO-FLUNISOLIDE NASAL SPRAY | 0.25MG | METERED-DOSE PUMP | Discontinued | 2018-02-26 | 2018-02-26 | 40965 |
| APO-FLUVOXAMINE TABLETS | 50MG | TABLET | Discontinued | 2017-03-30 | 2018-02-05 | 4716 |
| APO-FLUVOXAMINE TABLETS | 100MG | TABLET | Discontinued | 2017-03-30 | 2018-02-05 | 4713 |
| APO-GAIN LIQ 20MG/ML | 20MG | SOLUTION | Discontinued | 2019-01-02 | 2019-01-02 | 70815 |
| APO-GAIN LIQ 20MG/ML | 20MG | SOLUTION | Discontinued | 2018-02-26 | 2018-02-26 | 40997 |
| APO-GEMFIBROZIL | 600MG | TABLET | Discontinued | 2017-03-31 | 2017-03-31 | 4927 |
| APO-GEMFIBROZIL CAP 300MG USP | Discontinued | 2019-06-12 | 2019-06-12 | 86557 | ||
| APO-GEMFIBROZIL CAP 300MG USP | 300MG | CAPSULE | Discontinued | 2017-03-31 | 2018-12-07 | 4920 |
| APO-GLICLAZIDE | 80MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60512 |
| APO-GLIMEPIRIDE | Discontinued | 2019-09-20 | 2019-09-20 | 94446 | ||
| APO-GLIMEPIRIDE | Discontinued | 2019-09-20 | 2019-09-20 | 94452 | ||
| APO-GLIMEPIRIDE | Discontinued | 2019-09-20 | 2019-09-20 | 94449 | ||
| APO-HALOPERIDOL TAB 2MG | 2MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1084 |
| APO-HALOPERIDOL TAB 5MG | 5MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1087 |
| APO-HYDROMORPHONE CR | 18MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110965 |
| APO-HYDROMORPHONE CR | 30MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110971 |